33.50
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
VKTX Stock Down on Wider-Than-Expected Loss in Q2, Nil Sales - Yahoo Finance
Viking Therapeutics stock rating reiterated by Cantor Fitzgerald at $104 - Investing.com
Viking Therapeutics, Inc. (VKTX): A Bull Case Theory - Insider Monkey
Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: Navigating Increased R&D ... - Yahoo Finance
Is Viking Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - jammulinksnews.com
Viking Therapeutics Inc (VKTX) Q2 2025 Earnings Call Highlights: - GuruFocus
Viking Therapeutics Advances Clinical Pipeline Amid Financial Losses - TipRanks
Viking Therapeutics' Q2 2025 Earnings Call: Unpacking Key Contradictions in Phase III Study Strategy - AInvest
Viking Therapeutics EPS miss sends shares down 7% - MSN
Viking Therapeutics Posts Wider Q2 Loss - AOL.com
Viking Therapeutics EPS miss sends shares down 7% (VKTX:NASDAQ) - Seeking Alpha
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates - Benzinga
Viking Therapeutics, Inc. SEC 10-Q Report - TradingView
Viking Therapeutics shares fall as Q2 loss exceeds estimates By Investing.com - Investing.com India
Viking (VKTX) Q2 2025 Earnings Call Transcript - Mitrade
Viking Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | VKTX Stock News - GuruFocus
Viking Therapeutics Advances Dual Obesity Drug Strategy: Injectable Phase 3 Trials Begin as Oral Version Nears Data - Stock Titan
What analysts say about Viking Therapeutics Inc. stockSuperior stock selection - jammulinksnews.com
Viking Therapeutics (VKTX) Options Activity Surges Ahead of Earnings | VKTX Stock News - GuruFocus
Viking Therapeutics to Report Q2 2025 Financial Results on July 23, 2025 - AInvest
Viking Therapeutics, Inc. (NASDAQ:VKTX) institutional owners may be pleased with recent gains after 38% loss over the past year - Yahoo Finance
Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025 - Finansavisen
What drives Viking Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com
Viking Therapeutics (VKTX) Set to Release Q2 Earnings Results - GuruFocus
Better Growth Buy: Eli Lilly vs. Viking Therapeutics - Mitrade
Viking Therapeutics Inc. Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect - Yahoo Finance
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN
3 Monster Stocks in the Making to Buy Right Now - The Motley Fool
Viking Therapeutics VKTX 2025Q2 Earnings Preview Upside Potential Driven by Analyst Price Targets - AInvest
Viking Therapeutics (VKTX) Soars 9.7% on Looming Weight Loss Drug Trial Results - MSN
(VKTX) On The My Stocks Page - news.stocktradersdaily.com
Viking Therapeutics (VKTX) Soars 3.40% on Bullish Analyst Sentiment - AInvest
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):